SST and prostate carcinoma: UTS2 (Urotensin-II) is a somatostatin-like cyclic heptapeptide (Kim et al., 2017) and participates in the occurrence of different cancers, especially colon, breast, and prostate cancers (Giulianelli et al., 2019).